{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:09:16Z","timestamp":1780988956238,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["20K08517"],"award-info":[{"award-number":["20K08517"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The prognostic significance of absolute lymphocyte count (ALC) and absolute neutrophil count (ANC) remains unclear in patients with postoperative pneumonia (POP). The study objectives were to investigate the prognostic effects of ALC and ANC in POP patients, and to evaluate the time courses of ALC and ANC during hospitalization. This post-hoc analysis of a single-center prospective observational study evaluated consecutive POP patients, and comparatively analyzed community-acquired pneumonia (CAP) patients to highlight features of POP. In total, 228 POP patients and 1027 CAP patients were assessed. Severe lymphopenia (ALC\u2009&lt;\u2009500 cells\/\u03bcL) at diagnosis was associated with worse 90-day survival in both types of pneumonia. In POP patients, neutrophilia (ANC\u2009&gt;\u20097500 cells\/\u03bcL) was associated with better survival, whereas CAP patients with neutrophilia tended to have a lower survival rate. Prolonged lymphopenia and delayed increase in neutrophils were characteristic time-course changes of non-survivors in POP. The time courses of ALC and ANC between survivors and non-survivors in POP trended differently from those in CAP. Our study showed that ALC and ANC at pneumonia diagnosis can serve as prognostic factors in POP patients. Differences in time-course changes of ALC and ANC between survivors and non-survivors may provide important information for future immunological research in pneumonia.<\/jats:p>","DOI":"10.1038\/s41598-022-18794-5","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T10:03:17Z","timestamp":1661508197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effects of lymphocyte and neutrophil counts and their time courses on mortality in patients with postoperative pneumonia"],"prefix":"10.1038","volume":"12","author":[{"given":"Yasushi","family":"Murakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutaka","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyuki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"18794_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13054-015-0845-5","volume":"19","author":"N Allou","year":"2015","unstructured":"Allou, N. et al. Postoperative pneumonia following cardiac surgery in non-ventilated patients versus mechanically ventilated patients: Is there any difference?. Crit. Care 19, 116. https:\/\/doi.org\/10.1186\/s13054-015-0845-5 (2015).","journal-title":"Crit. Care"},{"key":"18794_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00134-002-1603-0","volume":"29","author":"H Dupont","year":"2003","unstructured":"Dupont, H. et al. Outcome of postoperative pneumonia in the Eole study. Intens. Care Med. 29, 179\u2013188. https:\/\/doi.org\/10.1007\/s00134-002-1603-0 (2003).","journal-title":"Intens. Care Med."},{"key":"18794_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00423-007-0271-5","volume":"393","author":"T Fujita","year":"2008","unstructured":"Fujita, T., Ishida, Y. & Yanaga, K. Impact of appropriateness of initial antibiotic therapy on outcome of postoperative pneumonia. Langenbecks Arch. Surg. 393, 487\u2013491. https:\/\/doi.org\/10.1007\/s00423-007-0271-5 (2008).","journal-title":"Langenbecks Arch. Surg."},{"key":"18794_CR4","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jamasurg.2014.1216","volume":"149","author":"HS Kazaure","year":"2014","unstructured":"Kazaure, H. S., Martin, M., Yoon, J. K. & Wren, S. M. Long-term results of a postoperative pneumonia prevention program for the inpatient surgical ward. JAMA Surg. 149, 914\u2013918. https:\/\/doi.org\/10.1001\/jamasurg.2014.1216 (2014).","journal-title":"JAMA Surg."},{"key":"18794_CR5","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.rmed.2015.07.008","volume":"109","author":"DF Simonsen","year":"2015","unstructured":"Simonsen, D. F., Sogaard, M., Bozi, I., Horsburgh, C. R. & Thomsen, R. W. Risk factors for postoperative pneumonia after lung cancer surgery and impact of pneumonia on survival. Respir. Med. 109, 1340\u20131346. https:\/\/doi.org\/10.1016\/j.rmed.2015.07.008 (2015).","journal-title":"Respir. Med."},{"key":"18794_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/01.sla.0000207097.38963.3b","volume":"243","author":"DA Thompson","year":"2006","unstructured":"Thompson, D. A., Makary, M. A., Dorman, T. & Pronovost, P. J. Clinical and economic outcomes of hospital acquired pneumonia in intra-abdominal surgery patients. Ann. Surg. 243, 547\u2013552. https:\/\/doi.org\/10.1097\/01.sla.0000207097.38963.3b (2006).","journal-title":"Ann. Surg."},{"key":"18794_CR7","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1001\/jama.2013.2773","volume":"309","author":"S Eappen","year":"2013","unstructured":"Eappen, S. et al. Relationship between occurrence of surgical complications and hospital finances. JAMA 309, 1599\u20131606. https:\/\/doi.org\/10.1001\/jama.2013.2773 (2013).","journal-title":"JAMA"},{"key":"18794_CR8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/thorax.58.5.377","volume":"58","author":"WS Lim","year":"2003","unstructured":"Lim, W. S. et al. Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax 58, 377\u2013382 (2003).","journal-title":"Thorax"},{"key":"18794_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJM199701233360402","volume":"336","author":"MJ Fine","year":"1997","unstructured":"Fine, M. J. et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 336, 243\u2013250 (1997).","journal-title":"N. Engl. J. Med."},{"key":"18794_CR10","doi-asserted-by":"publisher","first-page":"e46561","DOI":"10.1371\/journal.pone.0046561","volume":"7","author":"CP de Jager","year":"2012","unstructured":"de Jager, C. P. et al. The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia. PLoS ONE 7, e46561. https:\/\/doi.org\/10.1371\/journal.pone.0046561 (2012).","journal-title":"PLoS ONE"},{"key":"18794_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ebiom.2017.09.023","volume":"24","author":"JF Bermejo-Martin","year":"2017","unstructured":"Bermejo-Martin, J. F. et al. Lymphopenic community acquired pneumonia (L-CAP), an immunological phenotype associated with higher risk of mortality. EBioMedicine 24, 231\u2013236. https:\/\/doi.org\/10.1016\/j.ebiom.2017.09.023 (2017).","journal-title":"EBioMedicine"},{"key":"18794_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060843","author":"A Ceccato","year":"2019","unstructured":"Ceccato, A. et al. Lymphocytopenia as a predictor of mortality in patients with ICU-acquired pneumonia. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm8060843 (2019).","journal-title":"J. Clin. Med."},{"key":"18794_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8050754","author":"E Guell","year":"2019","unstructured":"Guell, E. et al. Impact of lymphocyte and enutrophil counts on mortality risk in severe community-acquired pneumonia with or without septic shock. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm8050754 (2019).","journal-title":"J. Clin. Med."},{"key":"18794_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jlb.54.4.283","volume":"54","author":"A Lee","year":"1993","unstructured":"Lee, A., Whyte, M. K. & Haslett, C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukoc. Biol. 54, 283\u2013288 (1993).","journal-title":"J. Leukoc. Biol."},{"key":"18794_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/SHK.0000000000000234","volume":"42","author":"AM Drewry","year":"2014","unstructured":"Drewry, A. M. et al. Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock 42, 383\u2013391. https:\/\/doi.org\/10.1097\/SHK.0000000000000234 (2014).","journal-title":"Shock"},{"key":"18794_CR16","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/SHK.0000000000000347","volume":"43","author":"KP Chung","year":"2015","unstructured":"Chung, K. P. et al. Severe lymphopenia is associated with elevated plasma interleukin-15 levels and increased mortality during severe sepsis. Shock 43, 569\u2013575. https:\/\/doi.org\/10.1097\/SHK.0000000000000347 (2015).","journal-title":"Shock"},{"key":"18794_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(19)30567-5","author":"I Rubio","year":"2019","unstructured":"Rubio, I. et al. Current gaps in sepsis immunology: New opportunities for translational research. Lancet Infect. Dis. https:\/\/doi.org\/10.1016\/s1473-3099(19)30567-5 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"18794_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/MCC.0000000000000227","volume":"21","author":"P Cui","year":"2015","unstructured":"Cui, P. & Fang, X. Pathogenesis of infection in surgical patients. Curr. Opin. Crit. Care 21, 343\u2013350. https:\/\/doi.org\/10.1097\/MCC.0000000000000227 (2015).","journal-title":"Curr. Opin. Crit. Care"},{"key":"18794_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/ACO.0000000000000331","volume":"29","author":"HD Torrance","year":"2016","unstructured":"Torrance, H. D., Pearse, R. M. & O\u2019Dwyer, M. J. Does major surgery induce immune suppression and increase the risk of postoperative infection?. Curr. Opin. Anaesthesiol. 29, 376\u2013383. https:\/\/doi.org\/10.1097\/ACO.0000000000000331 (2016).","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"18794_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2022.02.012","author":"M Sano","year":"2022","unstructured":"Sano, M. et al. Risk factors for antibiotic resistance in hospital-acquired and ventilator-associated pneumonia. J. Infect. Chemother. https:\/\/doi.org\/10.1016\/j.jiac.2022.02.012 (2022).","journal-title":"J. Infect. Chemother."},{"key":"18794_CR21","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil, A. C. et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin. Infect. Dis. 63, e61\u2013e111. https:\/\/doi.org\/10.1093\/cid\/ciw353 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"18794_CR22","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay, J. P. et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America. Am. J. Respir. Crit. Care Med. 200, e45\u2013e67. https:\/\/doi.org\/10.1164\/rccm.201908-1581ST (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"18794_CR23","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1164\/rccm.201301-0079OC","volume":"188","author":"Y Shindo","year":"2013","unstructured":"Shindo, Y. et al. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 188, 985\u2013995. https:\/\/doi.org\/10.1164\/rccm.201301-0079OC (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"18794_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/bjs.1800780327","volume":"78","author":"GP Copeland","year":"1991","unstructured":"Copeland, G. P., Jones, D. & Walters, M. POSSUM: A scoring system for surgical audit. Br. J. Surg. 78, 355\u2013360 (1991).","journal-title":"Br. J. Surg."},{"key":"18794_CR25","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/cc13728","volume":"18","author":"JF Bermejo-Martin","year":"2014","unstructured":"Bermejo-Martin, J. F. et al. Circulating neutrophil counts and mortality in septic shock. Crit. Care 18, 407. https:\/\/doi.org\/10.1186\/cc13728 (2014).","journal-title":"Crit. Care"},{"key":"18794_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/MOH.0b013e32833338f3","volume":"17","author":"RC Reddy","year":"2010","unstructured":"Reddy, R. C. & Standiford, T. J. Effects of sepsis on neutrophil chemotaxis. Curr. Opin. Hematol. 17, 18\u201324. https:\/\/doi.org\/10.1097\/MOH.0b013e32833338f3 (2010).","journal-title":"Curr. Opin. Hematol."},{"key":"18794_CR27","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1186\/cc13176","volume":"18","author":"K Chang","year":"2014","unstructured":"Chang, K. et al. Targeting the programmed cell death 1: Programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit. Care 18, R3. https:\/\/doi.org\/10.1186\/cc13176 (2014).","journal-title":"Crit. Care"},{"key":"18794_CR28","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.3389\/fimmu.2018.01926","volume":"9","author":"AM Peters van Ton","year":"2018","unstructured":"Peters van Ton, A. M., Kox, M., Abdo, W. F. & Pickkers, P. Precision Immunotherapy for Sepsis. Front. Immunol. 9, 1926. https:\/\/doi.org\/10.3389\/fimmu.2018.01926 (2018).","journal-title":"Front. Immunol."},{"key":"18794_CR29","doi-asserted-by":"publisher","first-page":"R172","DOI":"10.1186\/cc8148","volume":"13","author":"A Pelekanou","year":"2009","unstructured":"Pelekanou, A. et al. Decrease of CD4-lymphocytes and apoptosis of CD14-monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: Results from an observational study. Crit. Care 13, R172. https:\/\/doi.org\/10.1186\/cc8148 (2009).","journal-title":"Crit. Care"},{"key":"18794_CR30","doi-asserted-by":"publisher","first-page":"R96","DOI":"10.1186\/cc9031","volume":"14","author":"C Gogos","year":"2010","unstructured":"Gogos, C. et al. Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit. Care 14, R96. https:\/\/doi.org\/10.1186\/cc9031 (2010).","journal-title":"Crit. Care"},{"key":"18794_CR31","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1164\/rccm.201602-0368OC","volume":"194","author":"LA van Vught","year":"2016","unstructured":"van Vught, L. A. et al. Comparative analysis of the host response to community-acquired and hospital-acquired pneumonia in critically Ill patients. Am. J. Respir. Crit. Care Med. 194, 1366\u20131374. https:\/\/doi.org\/10.1164\/rccm.201602-0368OC (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"18794_CR32","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"C Qin","year":"2020","unstructured":"Qin, C. et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin. Infect. Dis. 71, 762\u2013768. https:\/\/doi.org\/10.1093\/cid\/ciaa248 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"18794_CR33","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 395, 1054\u20131062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3 (2020).","journal-title":"Lancet"},{"key":"18794_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10163595","author":"M Mart\u00ednez-Urbistondo","year":"2021","unstructured":"Mart\u00ednez-Urbistondo, M. et al. Severe lymphopenia as a predictor of COVID-19 mortality in immunosuppressed patients. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm10163595 (2021).","journal-title":"J. Clin. Med."},{"key":"18794_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030471","author":"J Lee","year":"2021","unstructured":"Lee, J., Park, S. S., Kim, T. Y., Lee, D. G. & Kim, D. W. Lymphopenia as a biological predictor of outcomes in COVID-19 patients: A nationwide cohort study. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers13030471 (2021).","journal-title":"Cancers (Basel)"},{"key":"18794_CR36","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/resp.12846","volume":"21","author":"A Ito","year":"2016","unstructured":"Ito, A., Ishida, T., Tachibana, H., Ito, Y. & Takaiwa, T. Serial procalcitonin levels for predicting prognosis in community-acquired pneumonia. Respirology 21, 1459\u20131464. https:\/\/doi.org\/10.1111\/resp.12846 (2016).","journal-title":"Respirology"},{"key":"18794_CR37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/23744235.2016.1253860","volume":"49","author":"SB Andersen","year":"2017","unstructured":"Andersen, S. B. et al. Failure of CRP decline within three days of hospitalization is associated with poor prognosis of Community-acquired Pneumonia. Infect. Dis. 49, 251\u2013260. https:\/\/doi.org\/10.1080\/23744235.2016.1253860 (2017).","journal-title":"Infect. Dis."},{"key":"18794_CR38","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s10096-011-1381-0","volume":"31","author":"A Lacoma","year":"2012","unstructured":"Lacoma, A. et al. Usefulness of consecutive biomarkers measurement in the management of community-acquired pneumonia. Eur. J. Clin. Microbiol. Infect. Dis. 31, 825\u2013833. https:\/\/doi.org\/10.1007\/s10096-011-1381-0 (2012).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"18794_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/00000658-199807000-00017","volume":"228","author":"M Shoup","year":"1998","unstructured":"Shoup, M. et al. Mechanisms of neutropenia involving myeloid maturation arrest in burn sepsis. Ann. Surg. 228, 112\u2013122. https:\/\/doi.org\/10.1097\/00000658-199807000-00017 (1998).","journal-title":"Ann. Surg."},{"key":"18794_CR40","doi-asserted-by":"publisher","first-page":"e12967","DOI":"10.1111\/sji.12967","volume":"93","author":"A Jafarzadeh","year":"2021","unstructured":"Jafarzadeh, A., Jafarzadeh, S., Nozari, P., Mokhtari, P. & Nemati, M. Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms. Scand. J. Immunol. 93, e12967. https:\/\/doi.org\/10.1111\/sji.12967 (2021).","journal-title":"Scand. J. Immunol."},{"key":"18794_CR41","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1182\/blood.V90.9.3356","volume":"90","author":"M Keel","year":"1997","unstructured":"Keel, M. et al. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 90, 3356\u20133363 (1997).","journal-title":"Blood"},{"key":"18794_CR42","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.immuni.2005.01.011","volume":"22","author":"MA Stark","year":"2005","unstructured":"Stark, M. A. et al. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22, 285\u2013294. https:\/\/doi.org\/10.1016\/j.immuni.2005.01.011 (2005).","journal-title":"Immunity"},{"key":"18794_CR43","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1128\/IAI.01213-09","volume":"78","author":"JT Muenzer","year":"2010","unstructured":"Muenzer, J. T. et al. Characterization and modulation of the immunosuppressive phase of sepsis. Infect. Immun. 78, 1582\u20131592. https:\/\/doi.org\/10.1128\/IAI.01213-09 (2010).","journal-title":"Infect. Immun."},{"key":"18794_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1189\/jlb.4A1215-581R","volume":"101","author":"Y Shindo","year":"2017","unstructured":"Shindo, Y. et al. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia. J. Leukoc. Biol. 101, 543\u2013554. https:\/\/doi.org\/10.1189\/jlb.4A1215-581R (2017).","journal-title":"J. Leukoc. Biol."},{"key":"18794_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01643-9","author":"FL van de Veerdonk","year":"2022","unstructured":"van de Veerdonk, F. L. et al. A guide to immunotherapy for COVID-19. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-021-01643-9 (2022).","journal-title":"Nat. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18794-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18794-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18794-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T10:20:12Z","timestamp":1661509212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18794-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["18794"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-18794-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]},"assertion":[{"value":"28 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The following information describes relevant financial activities outside of the submitted work. YS reports personal fees (payment for lectures, including service on speakers bureaus) from KYORIN Pharmaceutical Co., Ltd., AstraZeneca K.K., DAIICHI SANKYO COMPANY, LIMITED, Nippon Boehringer Ingelheim Co., Ltd., GlaxoSmithKline plc, and Gilead Sciences Inc. and participates as a member of the case adjudication committee of GlaxoSmithKline Biologicals SA. TY reports grants and personal fees (payment for lectures, including service on speakers bureaus) from Shionogi & Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., and MSD K.K. SM reports personal fees (payment for consultations in other studies) from Takeda Pharmaceutical Co., Ltd. YH reports grants and personal fees (payment for lectures, including service on speakers bureaus) from Chugai Pharmaceutical Co., Ltd., MSD K.K., GlaxoSmithKline plc, KYORIN Pharmaceutical Co., Ltd., Pfizer Japan Inc., Meiji Seika Pharma Co, Ltd., Sanofi K.K., and Daiichi Sankyo, Inc. All other authors have nothing to declare. The funders had no roles in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14564"}}